A carregar...

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

BACKGROUND: In models of dopaminergic neuronal loss, the dopamine agonist pramipexole has exhibited neuroprotective properties. The Pramipexole On Underlying Disease (PROUD) study was designed to identify whether early versus delayed pramipexole initiation has clinical and neuroimaging benefits in p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schapira, Anthony HV, McDermott, Michael P, Barone, Paolo, Comella, Cynthia L, Albrecht, Stefan, Hsu, Helen H, Massey, Daniel H, Mizuno, Yoshikuni, Poewe, Werner, Rascol, Olivier, Marek, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado em: Lancet Pub. Group 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3714436/
https://ncbi.nlm.nih.gov/pubmed/23726851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(13)70117-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!